Kevin Shokat, who developed a successful approach to drugging a protein produced by the KRAS gene, has received two prestigious scientific awards.

UCSF is a leading recipient of National Institutes of Health (NIH) funding for research, with a focus on advancing health sciences and medicine.

Proof of an over-the-counter allergy drug’s ability to reverse progression of multiple sclerosis provides monumental change for MS patients.

The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.

Oakland Promise’s Brilliant Baby program seeds $500 college funds for Medi-Cal-eligible babies, provides families with free financial coaching, and offers educational programming for caregivers.